Skip to main content

Advertisement

Log in

Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease

  • Original Article—Alimentary Tract
  • Published:
Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

Background

Prostasin (PRSS8) is a stimulator of epithelial sodium transport. In this study, we evaluated alteration of prostasin expression in the inflamed mucosa of patients with inflammatory bowel disease (IBD) and investigated the role of prostasin in the gut inflammation.

Methods

Prostasin expression was evaluated by immunohistochemical staining. Dextran sodium sulfate (DSS)-colitis was induced in mice lacking prostasin specifically in intestinal epithelial cells (PRSS8ΔIEC mice).

Results

In colonic mucosa of healthy individuals, prostasin was strongly expressed at the apical surfaces of epithelial cells, and this was markedly decreased in active mucosa of both ulcerative colitis and Crohn’s disease. DSS-colitis was exacerbated in PRSS8ΔIEC mice compared to control PRSS8lox/lox mice. Toll-like receptor4 (TLR4) expression in colonic epithelial cells was stronger in DSS-treated PRSS8ΔIEC mice than in DSS-treated PRSS8 lox/lox mice. NF-κB activation in colonic epithelial cells was more pronounced in DSS-treated PRSS8ΔIEC mice than in DSS-treated PRSS8lox/lox mice, and the mRNA expression of inflammatory cytokines was significantly higher in DSS-treated PRSS8ΔIEC mice. Broad-spectrum antibiotic treatment completely suppressed the exacerbation of DSS-colitis in PRSS8ΔIEC mice. The mRNA expression of tight junction proteins and mucosal permeability assessed using FITC-dextran were comparable between DSS-treated PRSS8lox/lox and DSS-treated PRSS8ΔIEC mice.

Conclusion

Prostasin has an anti-inflammatory effect via downregulation of TLR4 expression in colonic epithelial cells. Reduced prostasin expression in IBD mucosa is linked to the deterioration of local anti-inflammatory activity and may contribute to the persistence of mucosal inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig.5
Fig. 6

Similar content being viewed by others

References

  1. Verstockt B, Ferrante M, Vermeire S, et al. New treatment options for inflammatory bowel diseases. J Gastroenterol. 2018;53:585–90.

    Article  CAS  Google Scholar 

  2. Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease. Annu Rev Immunol. 2010;28:573–621.

    Article  CAS  Google Scholar 

  3. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–29.

    Article  CAS  Google Scholar 

  4. Aggarwal S, Dabla PK, Arora S. Prostasin: an epithelial sodium channel regulator. J Biomark. 2013;2013:179864.

    Article  Google Scholar 

  5. Vallet V, Chraibi A, Gaeggeler HP, et al. An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature. 1997;389:607–10.

    Article  CAS  Google Scholar 

  6. Caughey GH, Raymond WW, Blount JL, et al. Characterization of human gamma-tryptases, novel members of the chromosome 16p mast cell tryptase and prostasin gene families. J Immunol. 2000;164:6566–75.

    Article  CAS  Google Scholar 

  7. Malsure S, Wang Q, Charles RP, et al. Colon-specific deletion of epithelial sodium channel causes sodium loss and aldosterone resistance. J Am Soc Nephrol. 2014;25:1453–64.

    Article  CAS  Google Scholar 

  8. Leyvraz C, Charles RP, Rubera I, et al. The epidermal barrier function is dependent on the serine protease CAP1/Prss8. J Cell Biol. 2005;170:487–96.

    Article  CAS  Google Scholar 

  9. Frateschi S, Keppner A, Malsure S, et al. Mutations of the serine protease CAP1/Prss8 lead to reduced embryonic viability, skin defects, and decreased ENaC activity. Am J Pathol. 2012;181:605–15.

    Article  CAS  Google Scholar 

  10. Renard S, Voilley N, Bassilana F, et al. Localization and regulation by steroids of the alpha, beta and gamma subunits of the amiloride-sensitive Na+ channel in colon, lung and kidney. Pflugers Arch. 1995;430:299–307.

    Article  CAS  Google Scholar 

  11. Amasheh S, Barmeyer C, Koch CS, et al. Cytokine-dependent transcriptional down-regulation of epithelial sodium channel in ulcerative colitis. Gastroenterology. 2004;126:1711–20.

    Article  CAS  Google Scholar 

  12. Zeissig S, Bergann T, Fromm A, et al. Altered ENaC expression leads to impaired sodium absorption in the noninflamed intestine in Crohn’s disease. Gastroenterology. 2008;134:1436–47.

    Article  CAS  Google Scholar 

  13. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499–511.

    Article  CAS  Google Scholar 

  14. Akira S. Toll receptor families: structure and function. Semin Immunol. 2004;16:1–2.

    Article  CAS  Google Scholar 

  15. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nat Rev Microbiol. 2010;8:564–77.

    Article  CAS  Google Scholar 

  16. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298:82–6.

    Article  CAS  Google Scholar 

  17. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn’s Disease Activity Index (CDAI). Gastroenterology. 1979;77:843–6.

    Article  CAS  Google Scholar 

  18. Uchimura K, Hayata M, Mizumoto T, et al. The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling. Nat Commun. 2014;5:3428.

    Article  Google Scholar 

  19. Kim JJ, Shajib MS, Manocha MM, et al. Investigating intestinal inflammation in DSS-induced model of IBD. J Vis Exp. 2012. https://doi.org/10.3791/3678.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Obermeier F, Kojouharoff G, Hans W, et al. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol. 1999;116:238–45.

    Article  CAS  Google Scholar 

  21. Singh N, Gurav A, Sivaprakasam S, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity. 2014;40:128–39.

    Article  CAS  Google Scholar 

  22. Kusaka S, Nishida A, Takahashi K, et al. Expression of human cathelicidin peptide LL-37 in inflammatory bowel disease. Clin Exp Immunol. 2018;191:96–106.

    Article  CAS  Google Scholar 

  23. Nishida A, Hidaka K, Kanda T, et al. Increased expression of Interleukin-36, a member of the Interleukin-1 cytokine family, in inflammatory bowel disease. Inflamm Bowel Dis. 2016;22:303–14.

    Article  Google Scholar 

  24. Gupta J, del Barco BI, Igea A, et al. Dual function of p38alpha MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival. Cancer Cell. 2014;25:484–500.

    Article  CAS  Google Scholar 

  25. Nishida A, Lau CW, Zhang M, et al. The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice. Gastroenterology. 2012;142(865–874):e862.

    Google Scholar 

  26. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004;118:229–41.

    Article  CAS  Google Scholar 

  27. Hoffmann A, Levchenko A, Scott ML, et al. The IκB-NF-κB signaling module: temporal control and selective gene activation. Science. 2002;298:1241–5.

    Article  CAS  Google Scholar 

  28. Poritz LS, Garver KI, Green C, et al. Loss of the tight junction protein ZO-1 in dextran sulfate sodium induced colitis. J Surg Res. 2007;140:12–9.

    Article  CAS  Google Scholar 

  29. Eichele DD, Kharbanda KK. Dextran sodium sulfate colitis murine model: an indispensable tool for advancing our understanding of inflammatory bowel diseases pathogenesis. World J Gastroenterol. 2017;23:6016–29.

    Article  CAS  Google Scholar 

  30. Keppner A, Malsure S, Nobile A, et al. Altered prostasin (CAP1/Prss8) expression favors inflammation and tissue remodeling in DSS-induced colitis. Inflamm Bowel Dis. 2016;22:2824–39.

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan [18K08002 (A.A.), 16K09308 (O.I.), 16K9846 (M.K.) and 18K07909 (A.N.)], a grant for the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan [067 (A.A.)], a grant from the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED [15AeK0109047h0002 (A.A.)].

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akira Andoh.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (PPTX 782 kb)

Supplementary file2 (DOCX 21 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sugitani, Y., Nishida, A., Inatomi, O. et al. Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease. J Gastroenterol 55, 408–417 (2020). https://doi.org/10.1007/s00535-019-01660-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-019-01660-z

Keywords

Navigation